Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Fujioka

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Biomolecules|December 23, 2022
How Can Dupilumab Cause Eosinophilic Pneumonia?Momoko Kurihara, Katsunori Masaki, Emiko Matsuyama, et al.
Auris, Nasus, Larynx|June 20, 2020
Differences in hearing levels between siblings with hearing loss caused by GJB2 mutationsMasato Fujioka, Makoto Hosoya, Kiyomitsu Nara, et al.
Medicine|May 9, 2020
A phase I/IIa double blind single institute trial of low dose sirolimus for Pendred syndrome/DFNB4Masato Fujioka, Takumi Akiyama, Makoto Hosoya, et al.
Stem Cell Research|August 16, 2019
Generation of a human iPS cell line (CGMH.SLC26A4919-2) from a Pendred syndrome patient carrying SLC26A4 c.919-2A>G splice-site mutationYen-Fu Cheng, Yen-Hui Chan, Chin-Ju Hu, et al.
Nature Communications|April 23, 2020
Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2Ryota Tamura, Masato Fujioka, Yukina Morimoto, et al.
Nature Communications|December 19, 2019
A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2Ryota Tamura, Masato Fujioka, Yukina Morimoto, et al.
Auris, Nasus, Larynx|March 28, 2021
Multicenter phase III trial of regenerative treatment for chronic tympanic membrane perforationShin-Ichi Kanemaru, Rie Kanai, Koichi Omori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2024
Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related SchwannomatosisRyota Tamura, Yoshiharu Yamanobe, Masato Fujioka, et al.
Human Genetics|January 4, 2025
Genetic landscape in undiagnosed patients with syndromic hearing loss revealed by whole exome sequencing and phenotype similarity searchHideki Mutai, Fuyuki Miya, Kiyomitsu Nara, et al.
Scientific Reports|August 21, 2019
Comprehensive analysis of syndromic hearing loss patients in JapanMichie Ideura, Shin-Ya Nishio, Hideaki Moteki, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Biomolecules|December 23, 2022
How Can Dupilumab Cause Eosinophilic Pneumonia?Momoko Kurihara, Katsunori Masaki, Emiko Matsuyama, et al.
Auris, Nasus, Larynx|June 20, 2020
Differences in hearing levels between siblings with hearing loss caused by GJB2 mutationsMasato Fujioka, Makoto Hosoya, Kiyomitsu Nara, et al.
Medicine|May 9, 2020
A phase I/IIa double blind single institute trial of low dose sirolimus for Pendred syndrome/DFNB4Masato Fujioka, Takumi Akiyama, Makoto Hosoya, et al.
Stem Cell Research|August 16, 2019
Generation of a human iPS cell line (CGMH.SLC26A4919-2) from a Pendred syndrome patient carrying SLC26A4 c.919-2A>G splice-site mutationYen-Fu Cheng, Yen-Hui Chan, Chin-Ju Hu, et al.
Nature Communications|April 23, 2020
Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2Ryota Tamura, Masato Fujioka, Yukina Morimoto, et al.
Nature Communications|December 19, 2019
A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2Ryota Tamura, Masato Fujioka, Yukina Morimoto, et al.
Auris, Nasus, Larynx|March 28, 2021
Multicenter phase III trial of regenerative treatment for chronic tympanic membrane perforationShin-Ichi Kanemaru, Rie Kanai, Koichi Omori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2024
Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related SchwannomatosisRyota Tamura, Yoshiharu Yamanobe, Masato Fujioka, et al.
Human Genetics|January 4, 2025
Genetic landscape in undiagnosed patients with syndromic hearing loss revealed by whole exome sequencing and phenotype similarity searchHideki Mutai, Fuyuki Miya, Kiyomitsu Nara, et al.
Scientific Reports|August 21, 2019
Comprehensive analysis of syndromic hearing loss patients in JapanMichie Ideura, Shin-Ya Nishio, Hideaki Moteki, et al.
Pageof 8